Akagera Medicines

Website
Current Valuation
$345.0M
As of January 2, 2025
Total Funding Raised
$62.2M
Last Round
Later Stage VC

$30.0M

Last Funding
Jan 2025

Funding date

Capital Efficiency
5.54x

Valuation / Funding

Funding History & Valuation Timeline
Complete history of all funding rounds and valuation milestones

No funding history available

Funding data has not been imported for this company yet

Valuation Analysis

Current Valuation Metrics

Akagera Medicines is currently valued at $345.0M as of January 2, 2025. The company has raised a total of $62.2M in funding.

Capital Efficiency

With a capital efficiency ratio of 5.54x, Akagera Medicines has achieved a valuation that is 5.54 times the total capital raised.

Track Akagera Medicines Valuation Updates

Get notified when Akagera Medicines raises new funding or valuation changes

Explore More Data
Detailed analysis for Akagera Medicines

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock Akagera Medicines's valuation history, funding rounds, and growth metrics.

No credit card required

What is Akagera Medicines Worth in 2026?

Akagera Medicines is a leading private company in the technology sector. Track Akagera Medicines's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Akagera Medicines Valuation is Determined

Private company valuations like Akagera Medicines's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.